It's also just about the 2 year anniversary of me living a normal life and not caring.
Agree. That's when I likely had it based on the odd symptoms.Rapier108 said:
It was here in early December 2019 at the latest.
Secolobo said:
A Timeline of COVID-19 Developments in 2020 January 1, 2021 AJMC Staff
Quote:
June 29 Gilead Sets Price for Remdesivir at $3120
Gilead Sciences sets a price for remdesivir, which can shorten hospitalization stays for patients with COVID-19, at $520 a vial. With a treatment course of 6 vials, the typical treatment course will be $3120 per patient for people covered with private insurance. Critics of the price point are quick to point out that taxpayers funded the COVID-19 remdesivir trial through the National Institute of Allergy and Infectious Diseases.
...and it's still standard care if you end up in the hospital.Quote:
August 24 Remdesivir's Clinical Benefits Questioned
A global, multicenter study finds that the antiviral drug remdesivir had little effect on patients hospitalized with COVID-19. The findings, published in JAMA, indicate there were no significant differences in duration of supplemental oxygen or hospitalization between the intervention group given remdesivir and the control group given standard care.
Secolobo said:
A Timeline of COVID-19 Developments in 2020 January 1, 2021 AJMC Staff
That's impossible! We keep on being told that the vaccine was never promoted to prevent infections. It was always designed to just make you less sick!Quote:
November 16 Moderna Reveals Vaccine Efficacy Results
The positive vaccine news continues with Moderna's announcement that its experimental vaccine reduces the risk of COVID-19 infection by 94.5% in participants who received it. Like Pfizer's vaccine, the Moderna vaccine works using mRNA, an innovative approach that has not yet been used in approved vaccines against any disease.
GCRanger said:
Here is the thread that kicked it all off.
https://texags.com/forums/16/topics/3090341/1
Yeah, And I received it. Makes my stomach turn.FriscoKid said:Secolobo said:
A Timeline of COVID-19 Developments in 2020 January 1, 2021 AJMC StaffQuote:
June 29 Gilead Sets Price for Remdesivir at $3120
Gilead Sciences sets a price for remdesivir, which can shorten hospitalization stays for patients with COVID-19, at $520 a vial. With a treatment course of 6 vials, the typical treatment course will be $3120 per patient for people covered with private insurance. Critics of the price point are quick to point out that taxpayers funded the COVID-19 remdesivir trial through the National Institute of Allergy and Infectious Diseases....and it's still standard care if you end up in the hospital.Quote:
August 24 Remdesivir's Clinical Benefits Questioned
A global, multicenter study finds that the antiviral drug remdesivir had little effect on patients hospitalized with COVID-19. The findings, published in JAMA, indicate there were no significant differences in duration of supplemental oxygen or hospitalization between the intervention group given remdesivir and the control group given standard care.